anti-L1CAM mAbs (Elthera)

N/A

Report date: 2025/06/11 10:42:57

Base Information

Drug Nameanti-L1CAM mAbs (Elthera)
Drug Alias Nameanti-L1 monoclonal antibodies (MediGene/Celltrion)anti-L1 monoclonal antibodies (DKFZ)L1-9.3anti-L1 cell adhesion molecule mAbs (Elthera)P-437 +[8] 
ClassificationDiagnostic agent (In vivo)Biologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Monoclonal antibody humanized
Mechanisms of ActionNeural cell adhesion molecule L1 inhibitors
TargetsNeural cell adhesion molecule L1
Therapy Area/IndicationsOvarian NeoplasmsPancreatic NeoplasmsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermanySwitzerlandSouth Korea
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesGerman Cancer Research Center (Dkfz)
China Registration ClassN/A

Develop Information

Active CompaniesElthera AG
Inactive CompaniesGerman Cancer Research Center (Dkfz)Medigene AgCelltrion Inc
Active IndicationsOvarian NeoplasmsPancreatic Neoplasms
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A